October 2017

CicloMed Announces FDA Clearance, Trials at KU Cancer Center

CicloMed LLC announced that its development candidate for non-muscle-invasive and muscle-invasive bladder cancer, Ciclopirox Prodrug, was cleared by the U.S. Food and Drug Administration to begin human clinical trials at The University of Kansas Cancer Center. Learn More >

K-State to Help New $2.4M Initiative to Improve Healthy Food Access for Kansans

To help improve Kansans’ access to healthy food, the Kansas Health Foundation is launching the Kansas Healthy Food Initiative. Of the $4.2 million toward the initiative, $866,000 is going to Kansas State University’s Center for Engagement and Community Development. Learn More >  

UMKC Researcher Contributed to Nobel Prize Project

Jeffrey Price, PhD, associate professor at the University of Missouri-Kansas City School of Biological Sciences, is an author of two of the seven key publications on circadian rhythms that led up to this year’s Nobel Prize in Medicine. Learn More > 

Click here for a full list of stories.

Share:

Interested in Getting more involved with BioNexus KC and our events?